Historical background and safety tragedy
In 1956, thalidomide was launched on the global market as an innovative, "miraculous," and safe sleep aid that was not a barbiturate derivative. The drug was actively prescribed to pregnant women to relieve morning sickness.
However, in 1961, it was discovered that the drug causes severe embryonic developmental disorders. Due to its catastrophic teratogenic effect, thalidomide was urgently withdrawn from all markets. This historical precedent forced the pharmaceutical industry to completely revise preclinical trial standards and drug safety control.
Modern pharmacodynamics and mechanism of action
Decades later, scientists returned to studying the drug, revising its properties. Today, thalidomide and its analogs (e.g., lenalidomide) are considered potent anti-inflammatory and immunomodulating agents.
Key pharmacological effects include:
- Primary pathway: inhibition of tumor necrosis factor-alpha (TNF-α) activity.
- Reduction of neutrophil phagocytic activity.
- Increased expression of interleukin-10 (IL-10).
Clinical application
Due to its immunomodulatory profile, thalidomide has found a narrow but important application in modern medical practice.
Approved indications:
- Multiple myeloma.
- Leprosy.
In addition, the drug is undergoing active clinical trials as a promising treatment for autoimmune pathologies (rheumatoid arthritis, Crohn's disease), certain infections (AIDS), and solid tumors (colorectal cancer, melanoma, renal cell and prostate carcinomas).
Safety Profile and Adverse Reactions
The use of the drug requires the strictest control due to an impressive list of side effects. The main contraindication remains pregnancy due to the high risk of embryonic malformations.
Other dangerous and frequent adverse reactions:
- Peripheral neuropathy.
- Significantly increased risk of deep vein thrombosis.
- Hypothyroidism.
- General symptoms: constipation, skin rash, and general fatigue.
Briefly: answers to topical questions
What specific fetal birth defects does thalidomide cause?
- Phocomelia (phocomelia) is a congenital malformation of the limbs in which they resemble seal flippers.
This severe impairment of embryonic development occurs when the drug is used during the period of active organogenesis in early pregnancy and is a classic manifestation of delayed teratogenic action.
THALidomide — severe consequences: it gave birth to a teratogenic scandal that forced strict safety checks on drugs for pregnant women.
Class and exam questions
Why was thalidomide withdrawn from the market in 1961?
The drug caused a large-scale catastrophe due to its severe teratogenic action, disrupting normal fetal development in pregnant women who took it.
What is the main mechanism of action of thalidomide today?
Modern action is based on anti-inflammatory and immunomodulatory effects, the main link of which is the inhibition of tumor necrosis factor-alpha (TNF-α).
For which diseases is thalidomide officially used in medical practice?
To date, the approved indications for the drug's use are multiple myeloma and leprosy.
What else to study on this topic
- History of pharmacovigilance after the thalidomide scandal
- Comparative characteristics of thalidomide and lenalidomide
- Molecular mechanisms of the teratogenic action of glutamic acid derivatives
- The role of TNF-α inhibition in hematological malignancies
- Prevention of thrombosis during therapy with immunomodulatory drugs
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Thalidomide" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Regulating Immune Processes"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.